Fracture Risk in Women with Breast Cancer Initiating Aromatase Inhibitor Therapy: A Registry‐Based Cohort Study
The Oncologist is a journal devoted to medical and practice issues for surgical, radiation, and medical oncologists.
Related Articles
Volume 29 Issue 9 | The Oncologist | Oxford Academic
Published by OUP since 2022, The Oncologist is committed to helping physicians excel in the constantly changing fields of oncology and hematology through the publication…
Characterization of driver mutations identifies gene signatures predictive of prognosis and treatment sensitivity in multiple myeloma
This study aimed to enhance prognostic understanding of multiple myeloma by analyzing pathway dysregulations in key cancer driver genes to identify actiona
Arm symptom pattern among breast cancer survivors with and without lymphedema: a contemporaneous network analysis
This study aimed to construct symptom networks and visualize the interrelationships among arm symptoms in breast cancer survivors with and without lymphede
Treatment patterns for patients with BRCA1/2-positive metastatic castration-resistant prostate cancer
Patients with BRCA-positive metastatic castration-resistant prostate cancer have an aggressive disease course. This article describes real-world treatment
High sensitivity ctDNA assays in genitourinary malignancies: current evidence and future directions
Molecular residual disease (MRD) tests have the potential to revolutionize neoadjuvant and adjuvant treatment. This article reviews current evidence for th
Reevaluating the role of platinum-based chemotherapy in the evolving treatment landscape for patients with advanced urothelial carcinoma
This review reports currently recommended treatment options for advanced urothelial carcinoma, practical considerations with platinum-based chemotherapy, t
Outcomes in older adults with metastatic esophageal and gastric carcinoma treated with palliative chemotherapy
The incidence of esophageal and gastric carcinoma in elderly patients is increasing, yet patients ≥75 years have historically been underrepresented in clin
Efficacy and safety of camrelizumab, apatinib, and capecitabine combination therapy in advanced biliary tract cancer: a phase 2, nonrandomized, prospective study
Biliary tract cancer (BTC) is a highly malignant tumor, with limited therapy regimens and short response duration. This study assessed the efficacy and saf
Social supports in patients with cancer attending an Irish cancer center: a cross-sectional study
A positive association has been shown between social support, quality of life, and survival outcomes in cancer. This study assessed levels of social suppor
Assessment of psycho-oncology in the Middle East and North Africa region: a systematic review and meta-analysis
The burden of psycho-oncology is not yet established within the Middle East and North Africa region. This study reviewed all available evidence characteriz